Sponsor or institution

Clinical trials and research at 3D Medicines

As of November 12, 2026, Find a Trial lists 4 clinical trials run by 3D Medicines that are recruiting, in China. By phase: Phase 2 (2), Phase 1/2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
Envafolimab with chemotherapy for resectable stage III lung cancer Phase 3 Tianjin, Tianjin Municipality Recruiting Nov 9, 2023
Treatment of advanced endometrial cancer with Envafolimab and Lenvatinib Phase 2 Beijing, Beijing Municipality and 18 other locations Recruiting Nov 9, 2021
Combining Envafolimab and Lenvatinib for treating advanced solid tumors Phase 1/2 Bengbu, Anhui and 22 other locations Recruiting Aug 27, 2021
Treatment with Envafolimab for advanced solid tumors Phase 2 Beijing Recruiting May 18, 2021

All recruiting trials (4)

Quick answers

How many clinical trials run by 3D Medicines are recruiting right now?

4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.